FBIO Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own FBIO shares is 54, representing 15.78% of the company's common stock.

NANTAHALA CAPITAL MANAGEMENT, LLC, in the last quarter, reduced its stake in FBIO by -5.83% restricting it's holding to 6.02 million shares of worth nearly $1.75M. RAYMOND JAMES & ASSOCIATES also lessened -100% of the FBIO shares from its portfolio, reducing its holding to 0 shares of worth -. OPALEYE MANAGEMENT INC. also shunned FBIO shares holding by -39.58% last quarter which brought its holding to 2 million shares worth $580.60K.

As per its latest 13F filing, B. RILEY WEALTH ADVISORS, INC. increased its stake in FBIO by 100% in the last quarter. The institutional holder raised its holding to 144.7 thousand shares having worth more than $42.01K. VANGUARD GROUP INC also added 0.12% more shares of FBIO to its portfolio, raising its holding to 5.26 million shares of worth $1.53M. WEALTH ENHANCEMENT ADVISORY SERVICES, LLC also increased its FBIO shares holding by 100% which brought its holding to 1.54 million shares worth $447.64K.

The insider with the most stakes in FBIO is LOBELL J JAY , director at the company. Additionally, FBIO stock is highly held by 10 percent owner Fortress Biotech, Inc. and director Rowinsky Eric K among others.

Company executives, directors, and other insiders own 21.21% percent of Fortress Biotech, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which FBIO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KLEIN DOV, HUNTER ROBYN, and ROWINSKY ERIC K.

There have been 1 transaction(s) during the past 6-months in which Fortress Biotech, Inc. insiders have bought stock, totalling 763359 shares

Around 763.36K Fortress Biotech, Inc. shares are held by insiders, which represents about 21.21% of FBIO stock.

FBIO director, LOBELL J JAY holds the largest portfolio of the company's shares. FBIO shares owned by LOBELL total nearly 1.64 million.

B. RILEY WEALTH ADVISORS, INC. is the largest institutional owner in FBIO which holds 144.7 thousand shares worth $42.01K or 0.96% of the total FBIO shares outstanding followed by NANTAHALA CAPITAL MANAGEMENT, LLC with ownership of 6.02 million shares representing 5.44% of the FBIO ownership. VANGUARD GROUP INC is the third largest stakeholder with 5.26 million shares or 4.75% of the ownership worth more than $1.53M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the FBIO is concerned, it is a stock which is optionable.

Number of FBIO shares short is 2.62M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 27.60M shares of FBIO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, FBIO has 16.12M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for FBIO is 4.57.